Chabiotech Co.,Ltd. (KOSDAQ:085660)
11,140
-290 (-2.54%)
Sep 18, 2025, 2:40 PM KST
Chabiotech Revenue
Chabiotech had revenue of 298.90B KRW in the quarter ending June 30, 2025, with 12.94% growth. This brings the company's revenue in the last twelve months to 1.15T, up 18.08% year-over-year. In the year 2024, Chabiotech had annual revenue of 1.05T with 9.55% growth.
Revenue (ttm)
1,151.04B
Revenue Growth
+18.08%
P/S Ratio
0.75
Revenue / Employee
4.14B
Employees
278
Market Cap
868.18B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,045.05B | 91.10B | 9.55% |
Dec 31, 2023 | 953.95B | 109.37B | 12.95% |
Dec 31, 2022 | 844.58B | 117.11B | 16.10% |
Dec 31, 2021 | 727.48B | 62.76B | 9.44% |
Dec 31, 2020 | 664.72B | 130.11B | 24.34% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 5.18B |
PharmaResearch | 449.81B |
ABL Bio | 94.93B |